Cynata

Cynata

An Australian clinical-stage stem cell and regenerative medicine company focused on the development of therapies based on a proprietary therapeutic stem cell platform technology.

HQ location
Melbourne, Australia
Website
cynata.com
Launch date
Employees
2-10 people
Market cap
$21.9m
Enterprise value
$15m
Share price
AUD0.15 CYP.AX
https://twitter.com/cynatastemcellshttps://www.facebook.com/cynatatherapeuticshttps://www.linkedin.com/company/cynata-therapeutics/
    • Edit
loading funding rounds…
BioScience Managers Limited
BioScience Managers Limited
Australian Government for Research & Development
Australian Government for Research & Development
FUJIFILM
FUJIFILM
Fidelity International
Fidelity International
Innovation Connections
Innovation Connections
National Health and Medical Research Council
National Health and Medical Research Council

Financials

Estimates*

Get premium to view all results
Edit
Revenues, earnings & profits over time
AUD2020202120222023202420252026
Revenues0000000000000000000000000000
% growth250 %----(40 %)700 %
EBITDA0000000000000000000000000000
% EBITDA margin(146 %)---(530 %)--
Profit0000000000000000000000000000
% profit margin(52 %)---(421 %)--
EV0000000000000000000000000000
EV / revenue00.0x00.0x00.0x00.0x00.0x00.0x00.0x
EV / EBITDA00.0x00.0x00.0x00.0x00.0x00.0x00.0x
R&D budget0000000000000000000000000000
R&D % of revenue85 %---375 %--

Source: Company filings or news article, Equity research estimates

Related Content

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo